GO:0018963 phthalate metabolic process: Xenobiotic Biodegradation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0018963 phthalate metabolic process describes the chemical reactions and pathways that transform phthalate, the anion of phthalic acid, and related diesters such as di-n-butyl phthalate (DBP).
• Phthalate diesters are widely used as plasticizers in polymers, lubricating oils, and cosmetic carriers, making their environmental fate and human metabolism a major research focus.
• In humans, phthalate diesters are rapidly hydrolyzed to monoesters and then oxidatively metabolized to more hydrophilic products that are excreted in urine.
• Microbial degradation of phthalates, such as DBP by Enterobacter sp. DNB-S2, proceeds through stepwise ester hydrolysis and beta-oxidation-like pathways.
• Phthalate exposure has been associated with cardiovascular disease, Crohn's disease, dementia with Lewy bodies, and altered infant neurodevelopment.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of genes involved in phthalate metabolism and toxicity.
Description
GO:0018963 phthalate metabolic process is a Gene Ontology biological process term that covers the chemical reactions and pathways involving phthalate, the anion of phthalic acid, as well as related phthalic acid diesters. Phthalic acid diesters are used industrially in the production of household and consumer goods including plastic polymers, lubricating oils, and carriers for perfumes in cosmetics, while phthalic acid itself is used industrially as a plasticizer. Terephthalate, a related compound, is used in the synthesis of polyethylene terephthalate (PET), a plastic polymer with many commercial uses. Because phthalates are ubiquitous environmental contaminants, understanding their metabolic processing is critical for toxicology, environmental microbiology, and human health research. Research on phthalate metabolic process spans microbial biodegradation, plant transformation, and human xenobiotic metabolism. In humans, phthalate diesters are rapidly metabolized to monoesters and oxidative products that serve as urinary biomarkers of exposure. In microorganisms, phthalate-degrading strains such as Enterobacter sp. DNB-S2 can utilize di-n-butyl phthalate (DBP) as a carbon source through esterase and oxygenase activities. In plants, phthalate esters undergo novel transformation pathways that perturb metabolic networks. These diverse contexts make GO:0018963 a hub for studying xenobiotic detoxification, endocrine disruption, and environmental remediation. For researchers, GO:0018963 provides a structured framework to annotate genes and pathways involved in phthalate breakdown and to link them to disease associations such as cardiovascular disease, Crohn's disease, and dementia with Lewy bodies. The term also supports comparative studies across species, from bacteria to humans, and informs the design of CRISPR-based models to test gene function in phthalate metabolism.
phthalate metabolic process At A Glance
| GO ID | GO:0018963 |
|---|---|
| GO term | phthalate metabolic process |
| Ontology | biological_process |
| Synonym | phthalate metabolism; phthalic acid metabolic process; phthalic acid metabolism |
| Major function | Chemical reactions and pathways involving phthalate, the anion of phthalic acid, and related diesters |
| Industrial context | Phthalic acid diesters are used in plastic polymers, lubricating oils, and cosmetic carriers; phthalic acid is used as a plasticizer; terephthalate is used in PET synthesis |
| Human relevance | Phthalate diesters are rapidly metabolized to monoesters and oxidative products that are excreted in urine |
| Microbial relevance | Phthalate-degrading bacteria such as Enterobacter sp. DNB-S2 can utilize di-n-butyl phthalate as a carbon source |
| Disease associations | Phthalate exposure has been linked to cardiovascular disease, Crohn's disease, dementia with Lewy bodies, and altered infant neurodevelopment |
What Is GO:0018963?
GO:0018963 phthalate metabolic process is defined as the chemical reactions and pathways involving phthalate, the anion of phthalic acid. Phthalic acid diesters are used industrially in the production of a variety of household and consumer goods including plastic polymers, lubricating oils, and carriers for perfumes in cosmetics, while phthalic acid itself is used industrially as a plasticizer. Terephthalate is used in the synthesis of polyethylene terephthalate (PET or PETE), a plastic polymer with many commercial uses. In practice, this term encompasses enzymatic hydrolysis of phthalate diesters to monoesters, oxidative transformations, and downstream degradation or conjugation reactions that convert phthalates into more hydrophilic metabolites for excretion or further catabolism.
Why Is phthalate metabolic process Important in Cell Biology?
GO:0018963 phthalate metabolic process is important because phthalates are high-volume industrial chemicals with widespread human exposure, and their metabolic processing determines their toxicity, persistence, and excretion. Understanding this process supports risk assessment, biomonitoring, and the development of bioremediation strategies, while also revealing mechanistic links between phthalate exposure and diseases such as cardiovascular disease, Crohn's disease, and dementia with Lewy bodies.
• Phthalate diesters are used in plastic polymers, lubricating oils, and cosmetic carriers, leading to ubiquitous environmental and human exposure.
• Human metabolism of phthalates involves rapid hydrolysis to monoesters followed by oxidative metabolism, producing urinary biomarkers used in epidemiology.
• Microbial degradation of phthalates, such as DBP by Enterobacter sp. DNB-S2, is a model for bioremediation of contaminated soils.
• Phthalate exposure has been associated with cardiovascular disease in NHANES-based studies and network toxicology analyses.
• Urinary phthalate metabolites have been linked to Crohn's disease via oxidative stress, with gut microbiota as a potential moderator.
• Environmental phthalate exposure is associated with gut microbiota and metabolome changes in dementia with Lewy bodies.
• Prenatal phthalate exposure impacts the newborn metabolome and infant neurodevelopment.
• Phthalate esters interact with rice plants through novel transformation pathways and metabolic-network perturbations.
• Phthalic acid esters have natural sources and biological activities that broaden their relevance beyond industrial pollution.
• GO:0018963 provides a standardized annotation framework for comparative genomics and functional studies of phthalate metabolism.
What Happens During phthalate metabolic process?
Hydrolysis of phthalate diesters to monoesters
In simple terms: The first step is like cutting a two-handled molecule in half to make it easier to process.
In humans, phthalate diesters are rapidly hydrolyzed to their corresponding monoesters, a step that converts lipophilic parent compounds into more polar metabolites. This hydrolysis is a key initial reaction in the phthalate metabolic process and is mediated by esterases. The resulting monoesters are the primary urinary biomarkers used to assess human exposure to phthalates. In microbial systems, esterases also initiate the breakdown of di-n-butyl phthalate (DBP), as shown for Enterobacter sp. DNB-S2 isolated from Mollisol region in China.
Oxidative metabolism and phase I transformations
In simple terms: After the first cut, the molecule is further modified by adding oxygen to make it more water-soluble.
Following hydrolysis, phthalate monoesters undergo oxidative metabolism, including omega- and beta-oxidation of the alkyl side chains, generating secondary metabolites such as mono(2-ethyl-5-hydroxyhexyl) phthalate and mono(2-ethyl-5-oxohexyl) phthalate. These oxidative transformations increase hydrophilicity and facilitate excretion. In plants, phthalate esters undergo novel transformation pathways that perturb metabolic networks, indicating that oxidative processing is conserved across kingdoms. In bacteria, oxygenases and related enzymes further degrade phthalate intermediates.
Conjugation and excretion
In simple terms: The body tags the modified molecule for removal in urine.
Phase II conjugation reactions, such as glucuronidation, further increase the water solubility of phthalate metabolites and promote their excretion in urine. These conjugated metabolites are the analytes most commonly measured in human biomonitoring studies. The efficiency of conjugation and excretion influences the half-life of phthalate metabolites and their potential to interact with biological targets. In environmental settings, microbial communities can mineralize phthalate intermediates, completing the metabolic process.
Microbial degradation pathways
In simple terms: Bacteria can eat phthalates and break them down completely.
Microorganisms such as Enterobacter sp. DNB-S2 can utilize di-n-butyl phthalate (DBP) as a carbon source, degrading it through a metabolic process that involves ester hydrolysis and further oxidation. This microbial degradation is a model for bioremediation of phthalate-contaminated environments. The metabolic process in bacteria often converges on central intermediates such as protocatechuate, which then enter the tricarboxylic acid cycle. These pathways are relevant to soil and water remediation and to understanding the environmental fate of phthalates.
Plant transformation and metabolic-network perturbations
In simple terms: Plants can take up phthalates and change them in ways that affect their own metabolism.
Phthalate esters interact with rice plants through novel transformation pathways and cause metabolic-network perturbations. These transformations can produce conjugated or oxidized derivatives that differ from those seen in mammals or bacteria. The plant metabolic process for phthalates is relevant to food safety and to the environmental cycling of these compounds. Understanding these pathways helps assess the impact of phthalate contamination on crop plants and ecosystems.
Key Genes Involved in GO:0018963 phthalate metabolic process
The following genes and gene families have been implicated in phthalate metabolic process or in the biological response to phthalate exposure, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ESR1 | Estrogen receptor alpha; mediates endocrine-disrupting effects of phthalates | Phthalate exposure can interfere with estrogen signaling; relevant to reproductive and cardiovascular studies |
| PPARG | Peroxisome proliferator-activated receptor gamma; involved in lipid metabolism and phthalate-induced effects | Phthalates can activate PPAR gamma, linking metabolism to inflammation and cardiovascular risk |
| CYP450 family | Phase I oxidative enzymes that metabolize phthalate monoesters | Key for understanding inter-individual differences in phthalate metabolism |
| UGT family | UDP-glucuronosyltransferases that conjugate phthalate metabolites | Determine urinary excretion profiles and biomarker levels |
| CES family | Carboxylesterases that hydrolyze phthalate diesters to monoesters | Initial step in human phthalate metabolism; target for functional studies |
| GST family | Glutathione S-transferases involved in oxidative stress response | Phthalate exposure linked to oxidative stress in Crohn's disease |
| SOD1 | Superoxide dismutase 1; antioxidant defense | Oxidative stress mediation in phthalate-associated Crohn's disease |
| CAT | Catalase; antioxidant enzyme | Modulates oxidative stress from phthalate exposure |
| TNF | Tumor necrosis factor; inflammatory cytokine | Inflammation in phthalate-associated cardiovascular and gut diseases |
| IL6 | Interleukin 6; inflammatory cytokine | Inflammatory response to phthalate exposure |
| NQO1 | NAD(P)H quinone dehydrogenase 1; oxidative stress response | Network toxicology of phthalate-associated cardiovascular disease |
| HMOX1 | Heme oxygenase 1; antioxidant and stress response | Phthalate-induced oxidative stress pathways |
| AKT1 | Serine/threonine kinase; cell survival signaling | Network toxicology links phthalates to AKT signaling |
| MAPK1 | Mitogen-activated protein kinase 1; stress signaling | Phthalate exposure can activate MAPK pathways |
| TP53 | Tumor suppressor; DNA damage response | Phthalate-induced genotoxicity and oxidative stress |
| DNB-S2 esterase | Esterase in Enterobacter sp. DNB-S2 that hydrolyzes DBP | Microbial degradation model for bioremediation |
| Protocatechuate dioxygenase | Bacterial enzyme that cleaves protocatechuate in phthalate degradation | Central ring-cleavage step in microbial phthalate catabolism |
| Gut microbiota taxa | Community of microbes that modulate phthalate metabolism and toxicity | Moderating role in Crohn's disease and dementia with Lewy bodies |
How Is phthalate metabolic process Regulated?
Phthalate metabolic process is regulated at multiple levels. In humans, the expression and activity of carboxylesterases, cytochrome P450 enzymes, and UDP-glucuronosyltransferases determine the rate and profile of phthalate metabolism. Oxidative stress pathways, including glutathione S-transferases and antioxidant enzymes, modulate the cellular response to phthalate exposure and can influence disease associations such as Crohn's disease. Gut microbiota composition can moderate the relationship between urinary phthalate metabolites and oxidative stress, as shown in conditional mediation models. In microbial systems, the presence of phthalate-degrading enzymes such as esterases and dioxygenases is regulated by substrate availability and environmental conditions. In plants, phthalate exposure perturbs metabolic networks, indicating that endogenous regulatory pathways respond to phthalate stress.
phthalate metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ESR1 | Cardiovascular disease; endocrine disruption | Knockout and overexpression in cardiomyocytes or endothelial cells |
| PPARG | Cardiovascular disease; lipid metabolism | Point mutation and knockout in macrophages |
| GST family | Crohn's disease; oxidative stress | Knockout in intestinal epithelial cells |
| SOD1 | Crohn's disease; oxidative stress | Overexpression and knockout in gut organoids |
| Gut microbiota | Dementia with Lewy bodies; metabolome | Germ-free mouse models with microbiota transfer |
Cardiovascular disease
Exposure to phthalates has been associated with cardiovascular disease in a comprehensive study utilizing NHANES data from 2005 to 2018 and network toxicology. The analysis identified potential molecular targets and pathways linking phthalate metabolites to cardiovascular risk, including inflammatory and oxidative stress pathways. These findings suggest that phthalate metabolic process and its intermediates may contribute to cardiovascular pathology, warranting further mechanistic studies.
Crohn's disease and gut inflammation
Urinary phthalate metabolites have been associated with Crohn's disease via oxidative stress, with gut microbiota playing a potential moderating role in a conditional mediation model. This suggests that phthalate metabolism interacts with host antioxidant defenses and microbial communities to influence inflammatory bowel disease risk. The study highlights the importance of considering both metabolic and microbial factors in phthalate-related disease research.
Dementia with Lewy bodies
Environmental phthalate exposure has been associated with gut microbiota and metabolome alterations in dementia with Lewy bodies. This link suggests that phthalate metabolic process may influence neurodegeneration through microbiome-gut-brain axis mechanisms. Further research is needed to determine whether phthalate metabolites directly contribute to Lewy body pathology or serve as biomarkers of exposure.
Infant neurodevelopment
Prenatal phthalate exposure impacts the newborn metabolome and infant neurodevelopment, as shown in a 2025 study. The findings indicate that phthalate metabolic process during pregnancy may affect fetal metabolic programming and subsequent neurodevelopmental outcomes. These results underscore the need for understanding phthalate metabolism in vulnerable populations.
From phthalate metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CES1 knockout alter phthalate diester hydrolysis? | CRISPR knockout in HepG2 or HEK293 cells |
| Does a point mutation in ESR1 change phthalate-induced signaling? | CRISPR point mutation in breast cancer cell lines |
| Can knock-in of a tagged UGT enzyme track phthalate conjugation? | Tagged knock-in in hepatocytes |
| Does overexpression of antioxidant genes protect against phthalate toxicity? | Overexpression of SOD1 or CAT in intestinal cells |
| Which microbial genes are essential for DBP degradation? | CRISPR knockout in Enterobacter sp. DNB-S2 |
| Does gut microbiota modulate phthalate-induced oxidative stress? | Conditional mediation models with microbiota manipulation |
How to Study the phthalate metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS metabolomics | Quantification of phthalate metabolites in urine or cells | Human biomonitoring and exposure assessment |
| Microbial degradation assays | Rate and extent of phthalate breakdown by bacteria | Bioremediation and environmental microbiology |
| Network toxicology | Molecular interaction networks linking phthalates to disease genes | Predictive toxicology and disease mechanism discovery |
| 16S rRNA sequencing | Gut microbiota composition | Microbiota-phthalate interaction studies |
| CRISPR knockout screening | Gene essentiality for phthalate metabolism or toxicity | Functional genomics in cell models |
| RNA-seq | Transcriptional response to phthalate exposure | Pathway discovery and biomarker identification |
| Proteomics | Protein expression changes and post-translational modifications | Mechanistic studies of phthalate metabolism enzymes |
| Conditional mediation modeling | Statistical mediation of oxidative stress by microbiota | Epidemiological analysis of Crohn's disease |
Metabolomics and urinary biomarker profiling
Metabolomics approaches are used to profile phthalate metabolites in urine and other biological matrices, providing quantitative biomarkers of exposure and metabolism. These methods are essential for epidemiological studies linking phthalate exposure to diseases such as cardiovascular disease and Crohn's disease. High-resolution mass spectrometry enables the identification of novel metabolites and transformation products.
Microbial degradation assays
Microbial degradation assays using strains such as Enterobacter sp. DNB-S2 allow researchers to study the kinetics and pathways of phthalate breakdown. These assays can be combined with genomics and transcriptomics to identify genes involved in phthalate catabolism. Such methods are foundational for bioremediation research.
Network toxicology and bioinformatics
Network toxicology integrates phthalate exposure data with molecular interaction networks to predict disease associations and mechanisms. This approach has been used to link phthalates to cardiovascular disease and to identify potential gene targets. Bioinformatics analyses of gut microbiota and metabolome data further reveal associations with dementia with Lewy bodies.
CRISPR functional genomics
CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate genes in phthalate metabolism and toxicity. These models can be used in cell lines, organoids, and animal models to dissect the contribution of specific genes to phthalate-induced phenotypes. Functional genomics screens can identify novel regulators of phthalate metabolic process.
How CRISPR Can Be Used to Study GO:0018963 phthalate metabolic process
Knockout
CRISPR knockout is used to delete candidate genes involved in phthalate metabolism, such as CES1, UGT family members, or antioxidant genes, to determine their role in phthalate detoxification or toxicity. Knockout models can be generated in human cell lines, organoids, or animal models to test causal effects on metabolite profiles and disease phenotypes. In microbial systems, knockout of esterase or dioxygenase genes can confirm their necessity for phthalate degradation.
Point Mutation
CRISPR point mutation allows the introduction of specific amino acid changes in enzymes or receptors to test their functional impact on phthalate metabolism. For example, point mutations in ESR1 or PPARG can reveal how phthalate exposure alters receptor signaling. This approach is valuable for studying polymorphisms that affect human susceptibility to phthalate toxicity.
Knock-in
CRISPR knock-in can be used to insert tags, reporters, or humanized alleles into genes involved in phthalate metabolism, enabling real-time tracking of enzyme expression and localization. Tagged knock-in models of UGT or CYP enzymes facilitate studies of phthalate conjugation and oxidative metabolism. Knock-in of disease-associated variants can model inter-individual differences in phthalate handling.
Overexpression
CRISPR overexpression, often achieved by knock-in of a strong promoter or by CRISPR activation, can be used to increase the expression of detoxifying enzymes or antioxidant genes to test their protective effects against phthalate toxicity. Overexpression of SOD1 or CAT in intestinal cells can reduce phthalate-induced oxidative stress. This approach helps identify therapeutic targets for phthalate-associated diseases.
How EDITGENE Supports phthalate metabolic process Research
Researchers studying phthalate metabolic process-related genes often need to determine whether a candidate gene is causally involved in phthalate detoxification, metabolite production, or disease susceptibility. EDITGENE provides a comprehensive suite of CRISPR services to enable such functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for phthalate metabolic process research.
Frequently Asked Questions About phthalate metabolic process
What is GO:0018963 phthalate metabolic process?
GO:0018963 is a Gene Ontology biological process term describing the chemical reactions and pathways involving phthalate, the anion of phthalic acid, and related diesters.
What genes are involved in phthalate metabolic process?
Genes involved include CES family esterases, CYP450 enzymes, UGT family conjugating enzymes, ESR1, PPARG, and antioxidant genes such as SOD1 and CAT.
How are phthalates metabolized in humans?
Phthalate diesters are rapidly hydrolyzed to monoesters, then oxidatively metabolized and conjugated for urinary excretion.
Which bacteria can degrade phthalates?
Enterobacter sp. DNB-S2, isolated from Mollisol region in China, can degrade di-n-butyl phthalate (DBP).
What diseases are linked to phthalate exposure?
Phthalate exposure has been associated with cardiovascular disease, Crohn's disease, dementia with Lewy bodies, and altered infant neurodevelopment.
How does gut microbiota affect phthalate metabolism?
Gut microbiota can moderate the relationship between urinary phthalate metabolites and oxidative stress, influencing disease risk.
What are the main steps of phthalate metabolic process?
The main steps include hydrolysis of diesters to monoesters, oxidative metabolism, conjugation, and excretion.
Can CRISPR be used to study phthalate metabolism genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable functional studies of genes involved in phthalate metabolism.
What is the role of oxidative stress in phthalate toxicity?
Phthalate exposure can induce oxidative stress, which mediates associations with diseases such as Crohn's disease.
How do plants metabolize phthalates?
Plants such as rice can transform phthalate esters through novel pathways that perturb metabolic networks.
Conclusion
GO:0018963 phthalate metabolic process is a critical biological process that governs the fate of phthalates in humans, microorganisms, and plants. Understanding its mechanisms, from ester hydrolysis to oxidative metabolism and conjugation, is essential for assessing health risks and developing bioremediation strategies. The associations between phthalate exposure and diseases such as cardiovascular disease, Crohn's disease, and dementia with Lewy bodies highlight the need for continued research. CRISPR-based functional genomics, combined with metabolomics and bioinformatics, offers powerful tools to dissect the genes and pathways involved in phthalate metabolic process. EDITGENE supports this research with comprehensive CRISPR services, including knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics, enabling researchers to uncover causal mechanisms and therapeutic targets related to phthalate metabolism.
References
- 1. Sun R et al.. 2019. Metabolic process of di-n-butyl phthalate (DBP) by Enterobacter sp. DNB-S2, isolated from Mollisol region in China.. Environ Pollut 255(Pt 2):113344 PMID: 31668953
- 2. Gong W et al.. 2025. The association between exposure to phthalates and cardiovascular disease: A comprehensive study utilizing NHANES data from 2005 to 2018 and network toxicology.. Chem Biol Interact 420:111651 PMID: 40653100
- 3. Hoffman SS et al.. 2025. Impact of prenatal phthalate exposure on newborn metabolome and infant neurodevelopment.. Nat Commun 16(1):2539 PMID: 40175358
- 4. Xing H et al.. 2023. Interaction between Phthalate Ester and Rice Plants: Novel Transformation Pathways and Metabolic-Network Perturbations.. Environ Sci Technol 57(24):8870-8882 PMID: 37260373
- 5. Deng Z et al.. 2024. Association between environmental phthalates exposure and gut microbiota and metabolome in dementia with Lewy bodies.. Environ Int 190:108806 PMID: 38908272
- 6. Frederiksen H et al.. 2007. Metabolism of phthalates in humans.. Mol Nutr Food Res 51(7):899-911 PMID: 17604388
- 7. Xiong D et al.. 2023. Exploring the relationship between urinary phthalate metabolites and Crohn's disease via oxidative stress, and the potential moderating role of gut microbiota: A conditional mediation model.. Free Radic Biol Med 208:468-477 PMID: 37690673
- 8. Huang L et al.. 2021. Phthalic Acid Esters: Natural Sources and Biological Activities.. Toxins (Basel) 13(7) PMID: 34357967
